Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

News tagged with 'Adolescent Drug Use'

Posted by Jane Akre
January 08, 2009 12:41 PM

Hoping to continue the success of its blockbuster antipsychotic drug, Zyprexa, Eli Lilly has suffered a setback in its request for FDA approval of a longer-lasting formulation. Zyprexa is mired in controversy about the side effects and allegations that Lilly withheld important safety information.  

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact InjuryBoard.com

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes